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1. Introduction 
The specific affinity between enzymes and their 
physiological ligands (substrates, coenzymes) has 
been widely used for achieving selective labeling of 
enzyme active sites. This approach, most commonly 
referred to as ‘affinity labeling’ [I] has given rise to 
several variations and refinements, e.g., the introduc- 
tion of transition-state analogs and mechanism-based 
irreversible inhibitors. In affinity labeling reagents, 
the biorecognition elements (which target the reagent 
to the active site) and the chemically reactive group 
(which anchors the reagent at the active site) are both 
part of the same molecule, We describe here a case in 
which a carefully designed peptide substrate is used 
to preferentially channel a separate group-specific 
reagent to one (kinetically characterized) sulfhydryl 
group at the active site of CAMP-dependent protein 
kinase . 
2. Materials and methods 
The following materials were prepared according 
to described procedures: free catalytic subunit of 
cAMPdPK [2]; histone H2b [3]; the peptide LEU- 
Arg-Arg-Ala-Ser-Leu-Gly [4]. 
Abbreviations: CAMP, adenosine 3’:5’-cyclic monophosphate; 
cAMPdPK, CAMP-dependent protein kinase; C, catalytic sub- 
unit of cAMPdPK; Nbs,, 5,5’-dithiobis [ 2-nitrobenzoic acid] 
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[T-~~P]ATP (2.0-2.7 Ci/mmol) was obtained from 
the Radiochemical Centre, Amersham; Nbs2, 2,2’- 
dithiodipyridine, 2,2’-dithiobis[5-nitropyridine], 6,6’- 
dithiodinicotinic acid and 4,4’-dithiodipyridine were 
obtained from Sigma. 4,4’-dithiobis (3-nitrobenzoic 
acid) was a gift of Professor M. Fridkin. All other 
chemicals were best available grade from commercial 
sources. 
The assay of cAMPdPK was carried out as in [5]. 
The enzyme preparations used had spec. act. 8-13 
units/mg. One unit of enzyme activity is defined as 
the amount of enzyme which catalyzes the transfer 
of 1 pmol 32P from [Y-~~P] ATP onto histone H2b/ 
min at pH 6.5 and 30°C. 
Protein concentrations were determined by the 
method in [6]. Mr = 40 000 was used for the C sub- 
unit of cAMPdPK [7] and Mr = 13 800 for histone 
H2b [8]. The chemical modification of the SH groups 
of the enzyme was monitored and analyzed as in 
[9,101. 
3. Results and discussion 
Recent sequence studies have shown that the 
catalytic subunit (C) of cAMPdPK contains 2 Cys 
residues [ 111. When the SH groups of these residues 
are allowed to react with Nbsz at neutral pH and an 
ionic strength of 0.22, the enzyme is inactivated, 
both the inactivation and the SH modification taking 
place with monophasic kinetics (fig.1, cf. also [9]). 
However, if the reaction is done at an ionic strength 
of 0.03, two clear-cut phases can be distinguished in. 
the modification process: a slower phase (rate con- 
stant I, fig.1 B) corresponding to the titration of 
0.9 + 1 .O mol/SH groups/m01 C and attributed to 
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Fig.1. Effect of ionic strength, of histone H2b and of the 
heptapeptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly) on the 
rate constants of modification of SHf (denoted I) and SHH 
(denoted II) by Nbs,, as well as on the rate of inactivation of 
the enzyme (denoted ‘i’) by this reagent. The modification 
was carried out at pH 7.0 and 23°C with a -50-fold molar 
excess of Nbs, over the enzyme (4.8 PM), as in [ 91. Note that 
the modification of the SH groups is monophasic in the 
presence of histone H2b (36 PM) but biphasic in the presence 
of the heptapeptide (2mM). 
SH, [9], and a faster phase (rate constant If, fig.1 B) 
corresponding to the titration of 1 .O + 0.1 mol SW 
groups/m01 C and attributed to SH,,. Under these 
conditions, the inactivation of the enzyme (rate con- 
stant ‘i’, fig.lB) occurs concomitantly and stoichiom- 
etrically with the modification of SH,, [9], suggesting 
that this SH group might be located at the active site 
of the enzyme. In addition, the rate of inactivation of 
the enzyme and the rate of modification of SH,, 
were found to be dramatically attenuated in the 
presence of MgATP, the nucleoti.de substrate of the 
kinase. In the absence of the 7-P (as in MgADP) the 
protection afforded by the nucleotide substrate analog 
was considerably lowered, and in the absence of both 
the 7-P and /3-P (as in MgAMP) there was no protec- 
tion from inactivation. On the basis of these results 
it was concluded that SH,, is at least structurally 
associated with the 7-P subsite of the ATP binding 
site in C, if it does not constitute an integral part of it. 
Since the catalytic function of cAMPdPK is to 
transfer the 7-P from ATP onto a target serine residue 
of the protein substrate, it seemed obvious that the 
subsites accomodating these two substrates are 
vicinal in the 3-dimensional structure of the enzyme, 
and therefore that the presence of a protein substrate 
at its site might affect the chemical reactivity of Ski,, 
and consequently the inactivation of the enzyme by 
Nbs> Upon testing this assumption it was found that 
in contrast to MgATP (which dramatically attenuates 
the rate of inactivation of the enzyme by Nbsz) the 
protein substrate histone H2b brings about an opposite 
effect, considerably accelerating both this inactiva- 
tion, and the rate of chemical modification of the 
enzyme (fig.l,2). However, unlike MgATP (which 
exerts its protective effect on SH, only), histone H2b 
accelerates the rate of modification of the two 
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Eig.2. Effect of histone H2b and of the heptapeptide (Leu- 
Arg-Arg-Ala-Ser-Leu-Gly) on the kinetics of inactivation 
of C (0) by Nbs, and on the rate of modification of SW1 
(denoted I) and of SHIl (denoted (II)). The reaction was 
done at pH 7.0 and 23°C with a -50-fold molar excess of 
Nbs, over the enzyme (4.8 PM) and the kinetics was mea- 
sured as in [9]: upper, reference experiment with no substrate 
added; center, experiment done in the presence of histone 
H2b (36 PM); iower, experiment done in the presence of the 
heptapeptid~ (2 mM). 
128 
Volume 130, number 1 FEBS LETTERS July 1981 
sulfhydryls in C, making the kinetics of the reaction 
monophasic (fig.2). 
As we have shown that modification of SH,, alone 
suffices to inactivate the kinase [9], it was reasonable 
to assume that the accelerated inactivation of the 
enzyme in the presence of histone H2b might be due 
to the increase in the reactivity of SH,, rather than 
SH,. Furthermore, it could be argued that if the 
modification of either one of the two SH groups 
could cause a full inactivation of the enzyme, then 
the rate constant of inactivation (i) should be equal 
to the sum of the rate constants for modification of 
the two sulfhydryls (I + II). In other words, the rate 
constant in the presence of histone H2b should be 
equal to -3 X lo4 M-’ , min-’ while under these 
conditions ‘i’ was determined to be -1.6 X lo4 
M-’ _ min-’ (fig.1 C), very close to the rate constant 
for the modification of one SH only. 
In view of the fact that histone H2b is a basic 
protein with a considerable net charge at neutral pH 
(where the Nbsz-modification of the enzyme is car- 
ried out), we attempted to find out whether the 
enhanced rate of modification observed in the presence 
of this protein does not arise simply from the fact 
that upon binding of this histone to the enzyme, the 
complex formed attracts the negatively charged Nbs, 
reagent and leads or ‘channels’ it to react with the SH 
groups of the enzyme (histone H2b has no SH groups 
that would react by themselves with this reagent). 
This working hypothesis was supported by the find- 
ing that the rate of inactivation of the enzyme in the 
presence of histone H2b is accelerated when nega- 
tively-charged Nbss analogs are used, but not when 
they are replaced by neutral analogs of this thiol 
reagent (fig.3). 
On the basis of these findings we tried to restrict 
the accelerating effect of histone H2b, which was 
exerted on both SH, and SH,, (making the kinetics 
of modification monophasic, fig.lC,2), and to limit 
it to the immediate vicinity of the ATP-binding site, 
i.e., to SH,, only. Such local preferential acceleration 
of the modification of SH,, was achieved by replacing 
the large histone H2b substrate with a much smaller 
substrate, the peptide Leu-Arg-Arg-Ala-Ser- 
Leu-Gly, which had been shown [4] to constitute a 
good substrate for cAMPdPK, with Km- and V,,-val- 
ues similar to those determined with histone H2b 
[9,w. 
As seen in fig.lD, this heptapeptide accelerates the 
rate of inactivation of C by NbsZ to almost the same 
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Fig.3. Correlation between the net charge of the Nbs, analog 
and the occurrence of an accelerated enzyme inactivation in 
the presence of histone H2b. The inactivation was allowed to 
proceed at pH 7.5 (23°C) and with -150-fold molar excess 
of Nbs, over the enzyme (60 nM). With each of the reagents 
used, the rate of inactivation of C alone (0) as well as the 
ability of histone H2b (0; final cont. 0.9 mg/ml) to affect the 
inactivation were monitored. 
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extent as histone H2b (cf. fig.lC,D). However, while 
in the case of histone H2b the kinetics of modifica- 
tion of the sulfhydryls is monophasic (both SH, and 
SH,, are modified at the same rate (fig.2)) in the case 
of the heptapeptide the modification of the SH groups 
in the enzyme is clearly biphasic, and the acceleration 
in the rate of modification occurs practically with 
SH,, only (fig.2). This preferential and restricted 
acceleration of SH,, is better reflected in the rate con- 
stants depicted in fig.1. Upon comparing the experi- 
ments ‘C’ and ‘D’ (fig.1) it is evident that the relative 
reactivity of SH,, to SH, increases from 1 in the 
presence of histone H2b to 40 in the presence of the 
heptapeptide. The fact that the relative rate of modi- 
fication of the two sulfhydryl groups in the enzyme 
can be made to reach such a high ratio (40: 1) sets the 
stage for achieving a selective preferential labeling of 
SH,,, since with such relative rates it becomes possible 
to essentially complete the modification of SH,, 
before SH, starts to be modified. 
Furthermore, since the label introduced upon 
reacting SH groups with Nbsz can be quantitatively 
removed with thiols under very mild conditions, the 
results presented above may also be used for the 
selective labeling of SH,. For example, it becomes 
possible to temporarily mask SH,, with Nbsz, label 
SH, with an alkylating reagent (such as ICH2COOH, 
a chloromethylketone [5]) and then unmask SH,, 
with 2-mercaptoethanol. 
The above results can be accounted for if the 
spatial relationship between SH,,, SH, and the active 
site of the enzyme (which accomodates ATP and the 
protein substrate) is assumed to be as schematically 
depicted in fig.4. 
According to this scheme, SH,, is located at the 
active site and more specifically, it is close to the 
subsite accomodating the y-P of ATP. Also, in the 
complex formed between the enzyme and its protein 
substrates, SH,, is vicinal to the essential arginyl or 
lysyl residues of such substrates [ 131, the positively 
charged residues adjacent to the serine which becomes 
phosphorylated during the catalytic event. Placing 
SH,, in this position could account for a large number 
of observations reported here, as well as in other 
publications from our laboratory. These include: 
(i) MgATP protects SH,, from reaction with NbsZ; 
PROTEIN SUBSTRATE site 
+PROTEIN 
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Fig.4. Schematic representation of the spatial relationship between SHII, SHI and the sites which accommodate ATP and the pro- 
tein (or peptide) substrates of the enzyme. 
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(ii) MgATP attenuates dramatically the inactivation 
of the enzyme by Nbsz, concomitantly and 
stoichiometrically with the above protec’tion; 
(iii) MgADP is much less effective in that respect and 
MgAMP fails altogether to afford protection 
both to SH,, (from reaction with Nbs*) and to 
the enzyme (from inactivation); 
(iv) Protein substrates such as histone H2b (or prota- 
mine) enhance the rate of inactivation of the 
enzyme by Nbsz and concomitantly the rate of 
modification of SH,, (but also of SH,); 
(v) A similar accelerated inactivation can be achieved 
by the heptapeptide Leu-kg-kg-Aa-Ser- 
Leu-Gly but in this case the enhanced rate of 
modification is restricted to SH,, only; 
(vi) For both (iv) and (v) the accelerated inactivation 
and modification is achieved with negatively 
charged analogs of Nbsz but not with similar 
analogs devoid of negative charge; 
(vii) Na-tOSyl- - L lysme-chloromethylketone (an 
affinity labeling reagent for lysine-recognizing 
sites in proteins) inactivates the enzyme with 
concomitant binding to SH,, [5]. This inactiva- 
tion does not take place (under the same condi- 
tions) with CICHzCOOH, and equally reactive 
reagent devoid of the structural elements of 
lysine; 
(viii) MgATP protects the enzyme from inactivation 
by this chloromethylketone [5]. 
It should be emphasized, however, that each of the 
above observations by itself might also be accounted 
for if SH,, were to be placed at another location in 
the enzyme molecule, a location which would be 
distal to the active site but structurally linked with it. 
For this to be the case, we would have to assume that 
the y-P of ATP upon binding to the active site triggers 
a conformational change in C that makes SH,, much 
less available to chemical reaction. In addition, we 
would have to assume that a covalent modification by 
Nbsz of SH,, alone suffices to trigger a conformational 
change which is reflected at the active site, bringing 
about inactivation of the enzyme. Furthermore, we 
would have to assume that protein substrates such as 
histone H2b and protamine, and even the heptapep- 
tide mentioned above, are capable of imposing a 
conformational change that would considerably 
enhance the reactivity of this distal SH,,. We would 
also have to assume that this enhanced reactivity 
would be restricted to negatively charged (but not to 
neutral) analogs of Nbs?. We would also have to 
assume a coincidental occurrence of a lysine recog- 
nizing site also at the vicinity of this distal SH,, . 
While we cannot, at this stage, completely dismiss 
the occurence of such a combination of possibilities, 
it seems that placing SH,, at the active site itself (fig.4) 
accounts for all the above observations and, what is 
more, it is a simpler and more plausible assumption. 
In any case, the labeling approach illustrated here, 
which is based on the combined use of a small, care- 
fully chosen substrate together with a separate group- 
specific reagent, is useful in and of itself, since it 
enables us to optimalize the specificity of tagging of a 
unique site in the enzyme. The SH,, group which is 
labeled here certainly resides in a location which is 
conformationally linked to the active site, if it does 
not actually reside at the active site proper [ 14,151. 
Therefore the labeling of this particular sulfhydryl is 
most useful in the preparation of derivatives of 
cAMPdPK for X-ray crystallography and for further 
structure-function studies. 
Generally speaking, the use of a substrate for 
channeling an appropriate companion-reagent o the 
active site of an enzyme has the following advantages: 
1. Since the chemically reactive moiety and the bio- 
recognition functional groups do not reside on the 
same molecule, the interference of undesirable side- 
reactions (e.g., ring closure) is minimized, both 
during synthesis and during the labeling reaction 
itself; 
2. When the affinity between the targeting moiety 
and the enzyme is not very high, it is possible to 
ensure saturation of the active site by increasing 
the concentration of the substrate only, without 
having to increase at the same time the concen- 
tration of the chemically reactive species. This 
favours active-site specificity by lowering the 
probability of attack at other loci of the enzyme. 
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